TipRanks
Go Ultimate55% OFF

Atea Pharmaceuticals (AVIR) Cash flow

Atea Pharmaceuticals Cash Flow

AVIR's free cash flow for Q2 2026 was $-37.08M. For the 2026 fiscal year, AVIR's free cash flow was increased by $0.00 and operating cash flow was $-37.08M. See a summary of the company’s cash flow.

Cash Flow
Cash FlowDec 25Dec 24Dec 23Dec 22Dec 21
$ -132.03M$ -135.50M$ -85.39M$ -120.98M$ -87.00M
$ 188.79M$ 56.10M$ 40.30M$ -455.41M$ -4.00K
$ -25.75M$ 267.00K$ 257.00K$ 370.00K$ 1.47M
$ 95.71M$ 64.70M$ 143.82M$ 188.66M$ 764.68M
$ -132.03M$ -135.50M$ -85.39M$ -122.92M$ -87.01M

Currency in USD

Atea Pharmaceuticals Cash Flow

-750M-500M-250M0250M500M750M20182019202020212022202320242025OperatingInvestingFinancing